Bolt Biotherapeutics
OverviewSuggest Edit
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. Its Immune-stimulating Antibody Conjugates (ISAC) eliminate tumors following systemic administration in preclinical studies and results in the development of immunological memory. The company also develops Myeloid Modulator Platform that reawakens myeloid cells to attack tumor cells.
| Type | Public | |
| Founded | 2015 | |
| HQ | Redwood City, CA, US | Map |
| Website | boltbio.com |
Recent NewsAll News
- Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference
- Bolt Biotherapeutics to Participate in Upcoming February Conferences
- Bolt Biotherapeutics Doses First Patient with BDC-1001 in Combination with OPDIVO® (nivolumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of HER2-Expressing Solid Tumors
- Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors
Key People/Management at Bolt Biotherapeutics
Randy Schatzman
Grant Yonehiro
Priti Hegde
Edith Perez
William P Quinn
Roy S. Herbst
Bolt Biotherapeutics Office Locations
Bolt Biotherapeutics Financials and Metrics
Bolt Biotherapeutics Revenue
| USD | |
|---|---|
Net income (Q1, 2021) | (24.5m) |
EBIT (Q1, 2021) | (18.4m) |
Market capitalization (6-May-2022) | 52.6m |
Closing stock price (6-May-2022) | 1.4 |
Cash (31-Mar-2021) | 95.5m |
EV | (32.2m) |
| USD | FY, 2018 |
|---|---|
Financial Leverage | -1 x |
Bolt Biotherapeutics Operating Metrics
Show all operating metricsBolt Biotherapeutics Cybersecurity Score
Bolt Biotherapeutics Environment, Social & Governance (ESG) Ratings
Bolt Biotherapeutics Online and Social Media Presence
239 Twitter followers
Bolt Biotherapeutics has 239 Twitter Followers. The number of followers has increased 1.3% month over month and increased 4.5% quarter over quarter
Bolt Biotherapeutics's Trends
Twitter Engagement Stats for @boltbio
97
Tweets
155
Following
239
Followers
3
Tweets last 30 days
5.7
Avg. likes per Tweet
100%
Tweets with engagement
Bolt Biotherapeutics News and Updates
Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference
Bolt Biotherapeutics to Participate in Upcoming February Conferences
Bolt Biotherapeutics Doses First Patient with BDC-1001 in Combination with OPDIVO® (nivolumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of HER2-Expressing Solid Tumors
Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors
Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Demonstrating a Safe and Well-tolerated Profile and Emerging Clinical Activity at the ESMO Immuno-Oncology Congress 2021
Bolt Biotherapeutics to Present Interim Clinical Data on BDC-1001 Phase 1/2 Clinical Trial at ESMO Immuno-Oncology Congress 2021
Bolt Biotherapeutics Frequently Asked Questions
When was Bolt Biotherapeutics founded?
Bolt Biotherapeutics was founded in 2015.
Who are Bolt Biotherapeutics key executives?
Bolt Biotherapeutics's key executives are Randy Schatzman, Grant Yonehiro and Priti Hegde.
How many employees does Bolt Biotherapeutics have?
Bolt Biotherapeutics has 63 employees.
What is Bolt Biotherapeutics revenue?
Latest Bolt Biotherapeutics annual revenue is $215 k.
What is Bolt Biotherapeutics revenue per employee?
Latest Bolt Biotherapeutics revenue per employee is $3.4 k.
Who are Bolt Biotherapeutics competitors?
Competitors of Bolt Biotherapeutics include Forbius, OncoQR ML and Nkarta Therapeutics.
Where is Bolt Biotherapeutics headquarters?
Bolt Biotherapeutics headquarters is located at 900 Chesapeake Dr, Redwood City.
Where are Bolt Biotherapeutics offices?
Bolt Biotherapeutics has an office in Redwood City.
How many offices does Bolt Biotherapeutics have?
Bolt Biotherapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies